시장보고서
상품코드
1429592

세계의 소아 백신 시장 보고서(2024년)

Pediatric Vaccine Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 175 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

소아 백신 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상됩니다. 2028년에는 연평균 11.8%의 복합 성장률(CAGR)로 834억 9,000만 달러 규모로 성장할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 감염성 질환의 유병률 증가, 침윤성 자궁경부암의 증가, 강력한 후기 파이프라인 및 신약 승인에 기인하는 것으로 추정됩니다. 예측 기간 동안 주목할 만한 동향으로는 시장 수요를 충족시키기 위한 혼합백신 개발, 효과적인 백신 제형을 위한 R&D에 대한 전략적 투자, 젊은 층을 위한 백신 개발 등이 있습니다. 또한, 장기적인 면역 방어력을 제공하는 약독화 생백신 제조, 백신 안전성을 높이기 위한 새로운 면역 공학 및 첨단 전달 시스템 활용, 제조 간소화 및 합리화를 위한 백신 개발 프로세스에 인공지능(AI)을 도입하는 데 초점을 맞추고 있습니다.

15세 이하에서 결핵, 디프테리아, 폐렴과 같은 만성 질환의 발병률 증가는 소아 백신 시장 확대에 기여할 것으로 예상됩니다. 만성 질환을 앓고 있는 소아 및 청소년은 감염으로 인한 중증화 및 합병증 위험이 증가하고 있습니다. 호주 통계청에 따르면 2022년 3월 기준 전체 인구의 약 절반(46.6%, 1,160만 명)이 적어도 한 가지 이상의 만성질환을 앓고 있는 것으로 나타났습니다. 이러한 소아 만성 질환의 유병률 증가는 이러한 질환에 대한 예방접종에 대한 수요를 증가시켜 소아 백신 시장의 성장을 촉진할 것입니다.

소아 질환의 발생률 증가는 가까운 장래에 소아 백신 시장의 성장을 촉진할 것으로 예상됩니다. 소아 질환은 유아기부터 사춘기까지 어린이가 앓는 다양한 질병을 포함하며, 심각도와 만성도가 다양합니다. 소아 질환 예방접종은 다양한 소아 질환을 예방하고 관리하는 데 필수적입니다. 이러한 백신은 신생아 및 어린이에게 투여되며 많은 감염성 질환에 대한 방어 효과를 제공합니다. 예를 들어, 2023년 4월 Asthma Lung UK의 데이터에 따르면 2021년과 2022년 사이에 영국과 웨일즈에서 천식 아동의 입원 일수가 149% 증가했으며 2020년에서 2021년 사이에 천식 증상으로 입원 한 아동의 수는 19,506 명으로 나타났습니다. 지난 2년 동안 7,850 명으로 증가했습니다. 따라서 소아 질환의 확산은 소아 백신 시장의 주요 촉진요인으로 작용하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • COVID-19에 의한 시장에 대한 영향

제5장 세계 시장 규모와 성장

  • 세계의 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 시장 규모 실적과 성장, 2018-2023년
  • 세계의 시장 규모 예측과 성장, 2023-2028년, 2033년

제6장 시장 세분화

  • 세계의 소아 백신 시장, 백신 유형별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 1가
  • 다가
  • 세계의 소아 백신 시장, 기술별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 생 백신
  • 무효화
  • 톡소이드
  • 접합체
  • 기타 기술
  • 세계의 소아 백신 시장, 용도별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 감염증
  • 알레르기

제7장 지역 및 국가 분석

  • 세계의 소아 백신 시장, 지역별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 세계의 소아 백신 시장, 국가별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 상황과 기업 개요

  • 소아 백신 시장 경쟁 상황
  • 소아 백신 시장 기업 개요
    • Merck &Co. Inc.
    • Serum Institute of India Pvt. Ltd.
    • Sanofi SA
    • Pfizer Inc.
    • AstraZeneca

제31장 기타 주요 및 혁신적인 기업

  • GlaxoSmithKline PLC
  • Sinovac Biotech Ltd
  • Zydus Cadila
  • Indian Immunologicals Limited
  • Panacea Biotec
  • Takeda Pharmaceutical Company
  • Mitsubishi Tanabe Pharma Corporation
  • Daiichi Sankyo
  • CSL Limited
  • BIO-MED
  • Sun Pharmaceutical Industries Ltd
  • Sinopharm
  • Walvax biotechnology
  • Fosun Pharma
  • BioNTech

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병

제35장 향후 전망과 가능성 분석

제36장 부록

ksm 24.03.21

Pediatric vaccines are medicinal formulations primarily administered to children to safeguard them against severe and often life-threatening diseases. These vaccines prepare a child's body to combat diseases more effectively by enhancing its natural defense mechanisms.

The primary classifications of pediatric vaccines are monovalent and multivalent. A monovalent vaccine comprises a single antigen strain. Various technologies, including live attenuated, inactivated, toxoid, conjugate, and others, are employed to confer immunity against infectious diseases, allergies, and cancer.

The pediatric vaccine market research report is one of a series of new reports from The Business Research Company that provides pediatric vaccine market statistics, including pediatric vaccines industry global market size, regional shares, competitors with a pediatric vaccine market share, detailed pediatric vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric vaccine industry. This pediatric vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pediatric vaccine market size has grown strongly in recent years. It will grow from $49.89 billion in 2023 to $53.52 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The expansion witnessed in the historical period can be attributed to a rise in the incidence of chronic diseases, the implementation of immunization policies to eliminate endemic diseases, and augmented funding dedicated to vaccine development.

The pediatric vaccine market size is expected to see rapid growth in the next few years. It will grow to $83.49 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. The anticipated growth in the forecast period can be ascribed to the rising instances of invasive cervical cancer, a robust late-stage pipeline, and approvals for new drugs, along with an increasing prevalence of infectious diseases. Notable trends in the forecast period include the creation of combination vaccines to meet market demand, strategic investments in research and development for effective vaccine formulations, and the development of vaccines tailored for the younger population. Additionally, there is a focus on crafting live attenuated vaccines to provide long-term immunity protection, utilizing new immunoengineering and advanced delivery systems to enhance vaccine safety, and implementing artificial intelligence (AI) in vaccine development processes for simplification and streamlined manufacturing.

The escalating prevalence of chronic diseases, including tuberculosis, diphtheria, and pneumonia, among individuals aged 15 years and below is set to contribute to the expansion of the pediatric vaccines market. The risk of severe disease outcomes and complications from infectious diseases is on the rise among children and adolescents with chronic conditions. As of March 2022, as reported by the Australian Bureau of Statistics, approximately half of the overall population (46.6% or 11.6 million) had at least one chronic condition. This heightened prevalence of chronic diseases in children increases the demand for immunization against these conditions, thereby propelling the growth of the pediatric vaccine market.

The increasing incidence of pediatric diseases is anticipated to drive the growth of the pediatric vaccine market in the foreseeable future. Pediatric diseases encompass a range of disorders affecting children from infancy to puberty, varying in severity and chronicity. Vaccinations for pediatric diseases are crucial for preventing and managing a diverse spectrum of pediatric disorders. Administered to newborns and children, these vaccines offer protection against numerous infectious illnesses. For example, in April 2023, data from Asthma + Lung UK revealed a 149% increase in hospital stays for children with asthma in England and Wales between 2021 and 2022. The number of children hospitalized with asthma symptoms during 2020 and 2021 was 19,506, compared to 7,850 in the previous two years. Consequently, the growing prevalence of pediatric diseases is a key driver for the pediatric vaccine market.

The demand for innovative vaccines is consistently increasing to provide enhanced immunization against challenging infectious diseases (e.g., tuberculosis, HIV/AIDS) and non-communicable chronic diseases such as cancer and neurodegenerative diseases. Novel approaches to vaccine development involve structural immunogenic design, gene-based vaccine platforms, and the formulation of effective adjuvant recombinant antigens. In response to the growing demand for novel vaccines, pediatric vaccine manufacturers and developers are continuously seeking innovation in vaccine design and manufacturing technologies. For example, in April 2023, Pfizer Inc., a US-based pharmaceutical manufacturing company, announced the US FDA approval of REVNAR 20, a 20-valent Pneumococcal Conjugate Vaccine for children and infants.

Major companies in the pediatric vaccine market are prioritizing product approvals to better cater to the needs of their existing consumers. ABRYSVO is an FDA-approved vaccine for use in pregnant women, aiming to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in children up to 6 months of age. For instance, in August 2023, Pfizer Inc., a US-based pharmaceutical manufacturing company, announced the US FDA approval of Pfizer's ABRYSVO vaccine for the prevention of Respiratory Syncytial Virus (RSV) in infants through active immunization of pregnant women at 32-36 weeks gestational age. This marks the first and only maternal vaccination approved in the United States to help protect newborns against lower respiratory tract illness (LRTD) and severe LRTD caused by RSV from birth to six months of age.

Major companies operating in the pediatric vaccine market report are Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi SA, Pfizer Inc., AstraZeneca, GlaxoSmithKline PLC, Sinovac Biotech Ltd., Zydus Cadila, Indian Immunologicals Limited, Panacea Biotec, Takeda Pharmaceutical Company, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo, CSL Limited, BIO-MED, Sun Pharmaceutical Industries Ltd., Sinopharm, Walvax biotechnology, Fosun Pharma, BioNTech, MCM Vaccine Company, Seqirus, Roche, Johnson & Johnson, Novartis, Connaught Laboratories, Inc., Wyeth-Ayerst, Grifols, Ataulfo de Paiva Foundation, Bio-Manguinhos-Institute of Technology on Immunobiologicals, Butantan Institute, Ezequiel Dias Foundation (FUNED), Sinergium

North America was the largest region in the pediatric vaccine market in 2023. Middle East is expected to be the largest growing region in the global pediatric vaccine market share during the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pediatric vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The pediatric vaccine market consists of sales of BCG vaccines, hepatitis B vaccines, pentavalent vaccines, and rotavirus vaccines. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pediatric Vaccine Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pediatric vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pediatric vaccine? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pediatric vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Vaccine Type: Monovalent; Multivalent
  • 2) By Technology: Live Attenuated; Inactivated; Toxoid; Conjugate; Other Technologies
  • 3) By Application: Infectious Disease; Allergy; Cancer
  • Companies Mentioned: Merck & Co. Inc.; Serum Institute of India Pvt. Ltd.; Sanofi SA; Pfizer Inc.; AstraZeneca
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pediatric Vaccine Market Characteristics

3. Pediatric Vaccine Market Trends And Strategies

4. Pediatric Vaccine Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Pediatric Vaccine Market Size and Growth

  • 5.1. Global Pediatric Vaccine Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Pediatric Vaccine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Pediatric Vaccine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pediatric Vaccine Market Segmentation

  • 6.1. Global Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Monovalent
  • Multivalent
  • 6.2. Global Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Live Attenuated
  • Inactivated
  • Toxoid
  • Conjugate
  • Other Technologies
  • 6.3. Global Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Infectious Disease
  • Allergy
  • Cancer

7. Pediatric Vaccine Market Regional And Country Analysis

  • 7.1. Global Pediatric Vaccine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Pediatric Vaccine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pediatric Vaccine Market

  • 8.1. Asia-Pacific Pediatric Vaccine Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pediatric Vaccine Market

  • 9.1. China Pediatric Vaccine Market Overview
  • 9.2. China Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pediatric Vaccine Market

  • 10.1. India Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pediatric Vaccine Market

  • 11.1. Japan Pediatric Vaccine Market Overview
  • 11.2. Japan Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pediatric Vaccine Market

  • 12.1. Australia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pediatric Vaccine Market

  • 13.1. Indonesia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pediatric Vaccine Market

  • 14.1. South Korea Pediatric Vaccine Market Overview
  • 14.2. South Korea Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pediatric Vaccine Market

  • 15.1. Western Europe Pediatric Vaccine Market Overview
  • 15.2. Western Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pediatric Vaccine Market

  • 16.1. UK Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pediatric Vaccine Market

  • 17.1. Germany Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pediatric Vaccine Market

  • 18.1. France Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pediatric Vaccine Market

  • 19.1. Italy Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pediatric Vaccine Market

  • 20.1. Spain Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pediatric Vaccine Market

  • 21.1. Eastern Europe Pediatric Vaccine Market Overview
  • 21.2. Eastern Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pediatric Vaccine Market

  • 22.1. Russia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pediatric Vaccine Market

  • 23.1. North America Pediatric Vaccine Market Overview
  • 23.2. North America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pediatric Vaccine Market

  • 24.1. USA Pediatric Vaccine Market Overview
  • 24.2. USA Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pediatric Vaccine Market

  • 25.1. Canada Pediatric Vaccine Market Overview
  • 25.2. Canada Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pediatric Vaccine Market

  • 26.1. South America Pediatric Vaccine Market Overview
  • 26.2. South America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pediatric Vaccine Market

  • 27.1. Brazil Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pediatric Vaccine Market

  • 28.1. Middle East Pediatric Vaccine Market Overview
  • 28.2. Middle East Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pediatric Vaccine Market

  • 29.1. Africa Pediatric Vaccine Market Overview
  • 29.2. Africa Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pediatric Vaccine Market Competitive Landscape And Company Profiles

  • 30.1. Pediatric Vaccine Market Competitive Landscape
  • 30.2. Pediatric Vaccine Market Company Profiles
    • 30.2.1. Merck & Co. Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Serum Institute of India Pvt. Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Sanofi SA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Pfizer Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. AstraZeneca
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Pediatric Vaccine Market Other Major And Innovative Companies

  • 31.1. GlaxoSmithKline PLC
  • 31.2. Sinovac Biotech Ltd
  • 31.3. Zydus Cadila
  • 31.4. Indian Immunologicals Limited
  • 31.5. Panacea Biotec
  • 31.6. Takeda Pharmaceutical Company
  • 31.7. Mitsubishi Tanabe Pharma Corporation
  • 31.8. Daiichi Sankyo
  • 31.9. CSL Limited
  • 31.10. BIO-MED
  • 31.11. Sun Pharmaceutical Industries Ltd
  • 31.12. Sinopharm
  • 31.13. Walvax biotechnology
  • 31.14. Fosun Pharma
  • 31.15. BioNTech

32. Global Pediatric Vaccine Market Competitive Benchmarking

33. Global Pediatric Vaccine Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pediatric Vaccine Market

35. Pediatric Vaccine Market Future Outlook and Potential Analysis

  • 35.1 Pediatric Vaccine Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Pediatric Vaccine Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Pediatric Vaccine Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제